TY  - RPRT
TI  - Acquired secondary HER2 mutations enhance HER2/MAPK signaling and promote resistance to HER2 kinase inhibition in HER2-mutant breast cancer
AU  - Marin, A.
AU  - Mamun, A. A.
AU  - Akamatsu, H.
AU  - Ye, D.
AU  - Sudhan, d. R.
AU  - Brown, B. P.
AU  - Eli, L.
AU  - Marcelain, K.
AU  - Meiler, J.
AU  - Arteaga, C. L.
AU  - Hanker, A. B.
PY  - 2022
DO  - 10.1101/2022.09.23.509246
UR  - https://www.biorxiv.org/content/10.1101/2022.09.23.509246v1
ID  - 10.1101/2022.09.23.509246
ER  -